1219 related articles for article (PubMed ID: 34038399)
1. Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Tang ASO; Wong QY; Yeo ST; Ting IPL; Lee JTH; Fam TL; Chew LP; Chua HH; Muniandy P
Am J Case Rep; 2021 May; 22():e931655. PubMed ID: 34038399
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.
Matono T; Suzuki S; Mori S; Ato M
Am J Trop Med Hyg; 2024 Mar; 110(3):483-486. PubMed ID: 38266303
[TBL] [Abstract][Full Text] [Related]
3. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series.
Faust L; Klowak M; MacRae C; Kopalakrishnan S; Showler AJ; Boggild AK
J Cutan Med Surg; 2021; 25(1):45-52. PubMed ID: 32869655
[TBL] [Abstract][Full Text] [Related]
5. Methemoglobinemia and dapsone levels in patients with leprosy.
Vieira JL; Riveira JG; Martins Ade N; Silva JP; Salgado CG
Braz J Infect Dis; 2010; 14(3):319-21. PubMed ID: 20835521
[TBL] [Abstract][Full Text] [Related]
6. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
[TBL] [Abstract][Full Text] [Related]
7. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
8. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
9. [Leprosy with an unusual course].
Desenfants A; Huguon E; Polfrit Y; Crouzat M; Rouleau V; Chassot V; Besson-Leaud L; Missotte I
Arch Pediatr; 2012 Nov; 19(11):1182-6. PubMed ID: 23037580
[TBL] [Abstract][Full Text] [Related]
10. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
Deps P; Guerra P; Nasser S; Simon M
Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
[TBL] [Abstract][Full Text] [Related]
12. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
[TBL] [Abstract][Full Text] [Related]
14. Neonatal methemoglobinemia due to transplacental transfer of dapsone.
Kabra NS; Nanavati RN; Srinivasan G
Indian Pediatr; 1998 Jun; 35(6):553-5. PubMed ID: 10216653
[No Abstract] [Full Text] [Related]
15. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
16. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
17. A rare variant of erythema nodosum leprosum: a case report.
Dave S; Thappa DM; Nori AV; Jayanthi S
Dermatol Online J; 2003 Dec; 9(5):11. PubMed ID: 14996384
[TBL] [Abstract][Full Text] [Related]
18. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
[No Abstract] [Full Text] [Related]
19. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Ranawaka RR; Mendis S; Weerakoon HS
Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Ji B; Perani EG; Petinom C; N'Deli L; Grosset JH
Antimicrob Agents Chemother; 1994 Apr; 38(4):662-7. PubMed ID: 8031029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
